Methioninase - CoronaCure
Latest Information Update: 28 May 2024
At a glance
- Originator CoronaCure
- Developer AntiCancer
- Class Antivirals; Enzymes
- Mechanism of Action Amino acid inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - COVID 2019 infections
Highest Development Phases
- No development reported COVID 2019 infections